325 related articles for article (PubMed ID: 20489057)
1. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease.
Marsh RA; Madden L; Kitchen BJ; Mody R; McClimon B; Jordan MB; Bleesing JJ; Zhang K; Filipovich AH
Blood; 2010 Aug; 116(7):1079-82. PubMed ID: 20489057
[TBL] [Abstract][Full Text] [Related]
2. Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency.
Wada T; Kanegane H; Ohta K; Katoh F; Imamura T; Nakazawa Y; Miyashita R; Hara J; Hamamoto K; Yang X; Filipovich AH; Marsh RA; Yachie A
Cytokine; 2014 Jan; 65(1):74-8. PubMed ID: 24084330
[TBL] [Abstract][Full Text] [Related]
3. Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency.
Marsh RA; Bleesing JJ; Filipovich AH
J Immunol Methods; 2010 Oct; 362(1-2):1-9. PubMed ID: 20816973
[TBL] [Abstract][Full Text] [Related]
4. Clinical and genetic characteristics of XIAP deficiency in Japan.
Yang X; Kanegane H; Nishida N; Imamura T; Hamamoto K; Miyashita R; Imai K; Nonoyama S; Sanayama K; Yamaide A; Kato F; Nagai K; Ishii E; van Zelm MC; Latour S; Zhao XD; Miyawaki T
J Clin Immunol; 2012 Jun; 32(3):411-20. PubMed ID: 22228567
[TBL] [Abstract][Full Text] [Related]
5. A rapid flow cytometric screening test for X-linked lymphoproliferative disease due to XIAP deficiency.
Marsh RA; Villanueva J; Zhang K; Snow AL; Su HC; Madden L; Mody R; Kitchen B; Marmer D; Jordan MB; Risma KA; Filipovich AH; Bleesing JJ
Cytometry B Clin Cytom; 2009 Sep; 76(5):334-44. PubMed ID: 19288545
[TBL] [Abstract][Full Text] [Related]
6. X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic.
Xu T; Zhao Q; Li W; Chen X; Xue X; Chen Z; Du X; Bai X; Zhao Q; Zhou L; Tang X; Yang X; Kanegane H; Zhao X
Eur J Pediatr; 2020 Feb; 179(2):327-338. PubMed ID: 31754776
[TBL] [Abstract][Full Text] [Related]
7. Clinical phenotype and functional analysis of a rare XIAP/BIRC4 mutation.
Vieth S; Ammann S; Schwarz K; Härtel C; Schultz C; Lehmberg K; Lauten M
Klin Padiatr; 2013 Nov; 225(6):343-6. PubMed ID: 24166087
[TBL] [Abstract][Full Text] [Related]
8. X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis.
Speckmann C; Lehmberg K; Albert MH; Damgaard RB; Fritsch M; Gyrd-Hansen M; Rensing-Ehl A; Vraetz T; Grimbacher B; Salzer U; Fuchs I; Ufheil H; Belohradsky BH; Hassan A; Cale CM; Elawad M; Strahm B; Schibli S; Lauten M; Kohl M; Meerpohl JJ; Rodeck B; Kolb R; Eberl W; Soerensen J; von Bernuth H; Lorenz M; Schwarz K; Zur Stadt U; Ehl S
Clin Immunol; 2013 Oct; 149(1):133-41. PubMed ID: 23973892
[TBL] [Abstract][Full Text] [Related]
9. Hemophagocytic lymphohistiocytosis in a female patient due to a heterozygous XIAP mutation and skewed X chromosome inactivation.
Holle JR; Marsh RA; Holdcroft AM; Davies SM; Wang L; Zhang K; Jordan MB
Pediatr Blood Cancer; 2015 Jul; 62(7):1288-90. PubMed ID: 25801017
[TBL] [Abstract][Full Text] [Related]
10. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency).
Pachlopnik Schmid J; Canioni D; Moshous D; Touzot F; Mahlaoui N; Hauck F; Kanegane H; Lopez-Granados E; Mejstrikova E; Pellier I; Galicier L; Galambrun C; Barlogis V; Bordigoni P; Fourmaintraux A; Hamidou M; Dabadie A; Le Deist F; Haerynck F; Ouachée-Chardin M; Rohrlich P; Stephan JL; Lenoir C; Rigaud S; Lambert N; Milili M; Schiff C; Chapel H; Picard C; de Saint Basile G; Blanche S; Fischer A; Latour S
Blood; 2011 Feb; 117(5):1522-9. PubMed ID: 21119115
[TBL] [Abstract][Full Text] [Related]
11. SAP and XIAP deficiency in hemophagocytic lymphohistiocytosis.
Yang X; Miyawaki T; Kanegane H
Pediatr Int; 2012 Aug; 54(4):447-54. PubMed ID: 22672194
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-related hemophagocytic lymphohistiocytosis complicated with coronary artery dilation and acute renal injury in a boy with a novel X-linked inhibitor of apoptosis protein (XIAP) variant: a case report.
Chen RY; Li XZ; Lin Q; Zhu Y; Shen YY; Xu QY; Zhu XM; Bai ZJ; Li Y
BMC Pediatr; 2020 Oct; 20(1):456. PubMed ID: 33008347
[TBL] [Abstract][Full Text] [Related]
13. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome.
Rigaud S; Fondanèche MC; Lambert N; Pasquier B; Mateo V; Soulas P; Galicier L; Le Deist F; Rieux-Laucat F; Revy P; Fischer A; de Saint Basile G; Latour S
Nature; 2006 Nov; 444(7115):110-4. PubMed ID: 17080092
[TBL] [Abstract][Full Text] [Related]
14. X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome.
Aguilar C; Latour S
J Clin Immunol; 2015 May; 35(4):331-8. PubMed ID: 25737324
[TBL] [Abstract][Full Text] [Related]
15. Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature.
Jin YY; Zhou W; Tian ZQ; Chen TX
Hum Immunol; 2016 Aug; 77(8):658-666. PubMed ID: 27288720
[TBL] [Abstract][Full Text] [Related]
16. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
Front Pediatr; 2019; 7():183. PubMed ID: 31231620
[TBL] [Abstract][Full Text] [Related]
17. A female patient with incomplete hemophagocytic lymphohistiocytosis caused by a heterozygous XIAP mutation associated with non-random X-chromosome inactivation skewed towards the wild-type XIAP allele.
Yang X; Hoshino A; Taga T; Kunitsu T; Ikeda Y; Yasumi T; Yoshida K; Wada T; Miyake K; Kubota T; Okuno Y; Muramatsu H; Adachi Y; Miyano S; Ogawa S; Kojima S; Kanegane H
J Clin Immunol; 2015 Apr; 35(3):244-8. PubMed ID: 25744037
[TBL] [Abstract][Full Text] [Related]
18. [An X-linked lymphoproliferative syndrome (XLP) caused by mutations in the inhibitor-of-apoptosis gene XIAP].
Rigaud S; Latour S
Med Sci (Paris); 2007 Mar; 23(3):235-7. PubMed ID: 17349275
[No Abstract] [Full Text] [Related]
19. [Progress of diagnosis and treatment of X-linked inhibitor of apoptosis deficiency].
Yang X; Kanegane H; Miyawaki T
Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):428-30. PubMed ID: 22931939
[No Abstract] [Full Text] [Related]
20. Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency.
Yang L; Booth C; Speckmann C; Seidel MG; Worth AJJ; Kindle G; Lankester AC; Grimbacher B; ; Gennery AR; Seppanen MRJ; Morris EC; Burns SO
J Allergy Clin Immunol; 2022 Aug; 150(2):456-466. PubMed ID: 34920033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
